Isochronous mass spectrometry at the RIKEN Rare-RI Ring facility

Nagae, Daisuke*; Abe, Yasushi*; Yamaguchi, Yoshitaka*; Suzaki, Fumi; 27 of others*

Physical Review C, 110(1), p.014310_1 - 014310_13, 2024/07

https://doi.org/10.1103/PhysRevC.110.014310

Giant dipole resonance photofission and photoneutron reactions in U and Th

Filipescu, D.*; Gheorghe, I.*; Goriely, S.*; Nishio, Katsuhisa; Utsunomiya, Hiroaki*; Suzaki, Fumi; Hirose, Kentaro; 10 of others*

Physical Review C, 109(4), p.044602_1 - 044602_23, 2024/04

https://doi.org/10.1103/PhysRevC.109.044602

Measurement of double-differential neutron yields for iron, lead, and bismuth induced by 107-MeV protons for research and development of accelerator-driven systems

Iwamoto, Hiroki; Nakano, Keita; Meigo, Shinichiro; Satoh, Daiki; Iwamoto, Yosuke; Sugihara, Kenta*; Nishio, Katsuhisa; Ishi, Yoshihiro*; Uesugi, Tomonori*; Kuriyama, Yasutoshi*; et al.

EPJ Web of Conferences, 284, p.01023_1 - 01023_4, 2023/05

https://doi.org/10.1051/epjconf/202328401023

For accurate prediction of neutronic characteristics for accelerator-driven systems (ADS) and a source term of spallation neutrons for reactor physics experiments for the ADS at Kyoto University Critical Assembly (KUCA), we have launched an experimental program to measure nuclear data on ADS using the Fixed Field Alternating Gradient (FFAG) accelerator at Kyoto University. As part of this program, the proton-induced double-differential thick-target neutron-yields (TTNYs) and cross-sections (DDXs) for iron, lead, and bismuth have been measured with the time-of-flight (TOF) method. For each measurement, the target was installed in a vacuum chamber on the beamline and bombarded with 107-MeV proton beams accelerated from the FFAG accelerator. Neutrons produced from the targets were detected with stacked, small-sized neutron detectors for several angles from the incident beam direction. The TOF spectra were obtained from the detected signals and the FFAG kicker magnet's logic signals, where gamma-ray events were eliminated by pulse shape discrimination. Finally, the TTNYs and DDXs were obtained from the TOF spectra by relativistic kinematics. The measured TTNYs and DDXs were compared with calculations by the Monte Carlo transport code PHITS with its default physics model of INCL version 4.6 combined with GEM and those with the JENDL-4.0/HE nuclear data library.

Measurement of 107-MeV proton-induced double-differential thick target neutron yields for Fe, Pb, and Bi using a fixed-field alternating gradient accelerator at Kyoto University

Iwamoto, Hiroki; Nakano, Keita; Meigo, Shinichiro; Satoh, Daiki; Iwamoto, Yosuke; Sugihara, Kenta; Nishio, Katsuhisa; Ishi, Yoshihiro*; Uesugi, Tomonori*; Kuriyama, Yasutoshi*; et al.

Journal of Nuclear Science and Technology, 60(4), p.435 - 449, 2023/04

https://doi.org/10.1080/00223131.2022.2115423

Double-differential thick target neutron yields (TTNYs) for Fe, Pb, and Bi targets induced by 107-MeV protons were measured using the fixed-field alternating gradient accelerator at Kyoto University for research and development of accelerator-driven systems (ADSs) and fundamental ADS reactor physics research at the Kyoto University Critical Assembly (KUCA). Note that TTNYs were obtained with the time-of-flight method using a neutron detector system comprising eight neutron detectors; each detector has a small NE213 liquid organic scintillator and photomultiplier tube. The TTNYs obtained were compared with calculation results using Monte Carlo-based spallation models (i.e., INCL4.6/GEM, Bertini/GEM, JQMD/GEM, and JQMD/SMM/GEM) and the evaluated high-energy nuclear data library, i.e., JENDL-4.0/HE, implemented in the particle and heavy iontransport code system (PHITS). All models, including JENDL-4.0/HE, failed to predict high-energy peaks at a detector angle of 5. Comparing the energy- and angle-integrated spallation neutron yields at energies of 20 MeV estimated using the measured TTNYs and the PHITS indicated that INCL4.6/GEM would be suitable for the Monte Carlo transport simulation of ADS reactor physics experiments at the KUCA.

New isomers in Cf

Orlandi, R.; Makii, Hiroyuki; Nishio, Katsuhisa; Hirose, Kentaro; Asai, Masato; Tsukada, Kazuaki; Sato, Tetsuya; Ito, Yuta; Suzaki, Fumi; Nagame, Yuichiro*; et al.

Physical Review C, 106(6), p.064301_1 - 064301_11, 2022/12

https://doi.org/10.1103/PhysRevC.106.064301

The Japan Health Physics Society Guideline on Dose Monitoring for the Lens of the Eye

Yokoyama, Sumi*; Tsujimura, Norio; Hashimoto, Makoto; Yoshitomi, Hiroshi; Kato, Masahiro*; Kurosawa, Tadahiro*; Tatsuzaki, Hideo*; Sekiguchi, Hiroshi*; Koguchi, Yasuhiro*; Ono, Koji*; et al.

Journal of Radiation Protection and Research, 47(1), p.1 - 7, 2022/03

https://doi.org/10.14407/jrpr.2021.00276

Background: In Japan, new regulations that revise the dose limit for the lens of the eye (the lens), operational quantities, and measurement positions for the lens dose were enforced in April 2021. Based on the international safety standards, national guidelines, the results of the Radiation Safety Research Promotion Fund of the Nuclear Regulatory Authority, and other studies, the Working Group of Radiation Protection Standardization Committee, the Japan Health Physics Society (JHPS) developed a guideline for radiation dose monitoring for the lens. Materials and Methods: The Working Group of the JHPS discussed the criteria of non-uniform exposure and the management criteria set to not exceed the dose limit for the lens. Results and Discussion: In July 2020, the JHPS guideline was published. The guideline consists of three parts: main text, explanations, and 26 questions. In the questions, the corresponding answers were prepared, and specific examples were provided to enable similar cases to be addressed. Conclusion: With the development of guideline on radiation dose monitoring of the lens, radiation managers and workers will be able to smoothly comply with revised regulations and optimise radiation protection.

The Fe(n,)Fe cross section from the surrogate ratio method and its effect on the Fe nucleosynthesis

Yan, S. Q.*; Li, X. Y.*; Nishio, Katsuhisa; Lugaro, M.*; Li, Z. H.*; Makii, Hiroyuki; Pignatari, M.*; Wang, Y. B.*; Orlandi, R.; Hirose, Kentaro; et al.

Astrophysical Journal, 919(2), p.84_1 - 84_7, 2021/10

https://doi.org/10.3847/1538-4357/ac12ce

Progress of divertor simulation research toward the realization of detached plasma using a large tandem mirror device

Nakashima, Yosuke*; Takeda, Hisahito*; Ichimura, Kazuya*; Hosoi, Katsuhiro*; Oki, Kensuke*; Sakamoto, Mizuki*; Hirata, Mafumi*; Ichimura, Makoto*; Ikezoe, Ryuya*; Imai, Tsuyoshi*; et al.

Journal of Nuclear Materials, 463, p.537 - 540, 2015/08

https://doi.org/10.1016/j.jnucmat.2014.12.063

Analysis on the Co-localization of asbestos bodies and Fas or CD163 expression in asbestos lung tissue by in-air micro-PIXE

Matsuzaki, Shinichi*; Shimizu, Yasuo*; Dobashi, Kunio*; Nagamine, Takeaki*; Sato, Takahiro; Okubo, Takeru; Yokoyama, Akihito; Ishii, Yasuyuki; Kamiya, Tomihiro; Arakawa, Kazuo*; et al.

International Journal of Immunopathology and Pharmacology, 23(1), p.1 - 11, 2010/01

https://doi.org/10.1177/039463201002300101

Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma; Correlation between radiation dose and radiation injury and clinical outcome

Kageji, Teruyoshi*; Nagahiro, Shinji*; Matsuzaki, Kazuhito*; Mizobuchi, Yoshifumi*; Toi, Hiroyuki*; Nakagawa, Yoshinobu*; Kumada, Hiroaki

International Journal of Radiation Oncology, Biology, Physics, 65(5), p.1446 - 1455, 2006/08

https://doi.org/10.1016/j.ijrobp.2006.03.016

Clinical trials for boron neutron capture therapy (BNCT) for malignant glioma were performed with thermal-epithermal mixed neutron beam generated by JRR-4. The first protocol (P1998) prescribed a maximal gross tumor volume (GTV) dose of 15 Gy since 1998, and then the protocol was applied to 8 patients. In 2001, a dose-escalated protocol (P2001) was introduced, which prescribed a maximal vascular volume dose of 15 Gy, or alternatively, a clinical target volume (CTV) dose of 18 Gy, the protocol was applied to 11 patients. The GTV and CTV doses in P2001 were 1.1-1.3 times greater than those in P1998. The maximal vascular volume dose of those with acute radiation injury was 15.8 Gy. The mean GTV and CTV dose in long-term survivors with glioblastoma was 26.4 and 16.5 Gy, respectively. A statistically significant correlation between the GTV dose and median survival time was found. In the 11 glioblastoma patients in P2001, the median survival time was 19.5 months and 1- and 2-year survival rate was 60.6 % and 37.9 %, respectively. Dose escalation contributed to the improvement in clinical outcome. To avoid radiation injury, the maximal vascular volume dose should be 12 Gy. For long-term survival in patients with glioblastoma after boron neutron capture therapy, the optimal mean dose of the GTV and CTV was 26 and 16 Gy, respectively. This report introduces principle of BNCT and the activities for the BNCT clinical trials using JRR-4 in JAEA, and the clinical outcomes of the trials under the protocols and radiation injury in the irradiation are described.